Tumor cells actively compete with antitumor immune effectors (including CD8+ T cells, NK cells, and dendritic cells) for glucose utilization, while concurrently promoting glycolysis in immunosuppressive populations such as myeloid‐derived suppressor cells (MDSCs) [40]. This evidence concerns the gene CD8A and neoplasm.